Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Like other members of the TNF family,
TRAIL
/Apo-2 ligand induces apoptosis in sensitive target cells in a caspase-dependent fashion. We recently found that
TRAIL
may be constitutively expressed on the surface of mouse and human tumor cells of T and B origin. To define the pattern of
TRAIL
expression in normal immune cells, freshly isolated splenocytes, Concanavalin A/IL-2-activated T cells and
lipopolysaccharide
-activated B cells were analyzed by surface staining with or without secondary stimulation. Activated, but not resting, CD3+ cells expressed
TRAIL
in an activation-dependent fashion. Conversely, freshly isolated B220+ cells displayed surface
TRAIL
and CD95L that were retained following activation. Restimulation with the protein kinase C activator phorbol 12-myristate 13-acetate and the calcium ionophore ionomycin or an agonistic anti-CD3 monoclonal antibody induced significant up-regulation of surface
TRAIL
and CD95L in CD3+, TCRalphabeta cells with CD4+ or CD8+ phenotype. Similarly to CD95L,
TRAIL
up-regulation was protein synthesis dependent and cyclosporin A sensitive. These results indicate that both
TRAIL
and CD95L are displayed on the cell surface of activated immune cells and may thus represent complementary effector pathways in the regulatory functions of T and B cells.
...
PMID:Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. 960 53
Monocytes express cytotoxic factors of the tumour necrosis factor (TNF) ligand superfamily, including TNF and Fas ligand, both on the cell surface and in secreted form. In this report, we show that human monocytes and monocyte-derived macrophages stimulated with
lipopolysaccharide
(
LPS
) express APO2 ligand (
APO2L
,
TRAIL
), a recently discovered cytotoxic member of the TNF ligand superfamily.
LPS
increased the transcription of
APO2L
mRNA in monocytes and macrophages. Flow cytometric analysis showed low surface and high intracellular levels of
APO2L
, and
LPS
increased the expression of both. In addition,
LPS
increased the monocyte- and macrophage-mediated cytotoxicity against the
APO2L
-sensitive Jurkat and RPMI-8226 cells. Addition of the
APO2L
-binding decoy receptor 1 (DcR1)-Fc fusion protein inhibited the cytotoxicity by 30-70%.
LPS
also stimulated the release of soluble
APO2L
from the monocytes and macrophages. Monocytic phagocytosis of target cells was increased by
LPS
and partially inhibited by DcR1-Fc. Taken together, these data demonstrate a novel mechanism of cytotoxicity mediated by
LPS
-activated human monocytes and macrophages.
...
PMID:Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. 1073 93
TWEAK, a new member of the tumor necrosis factor (TNF) family, induces cell death in some tumor cell lines, but its physiological functions are largely unknown. In this study, we investigated the expression and function of TWEAK in human peripheral blood mononuclear cells (PBMCs) by using newly generated anti-human TWEAK mAbs. Although freshly isolated PBMCs expressed no detectable level of TWEAK on their surfaces, a remarkable TWEAK expression was rapidly observed on monocytes upon stimulation with interferon (IFN)-gamma but not with IFN-alpha or
lipopolysaccharide
. Cytotoxic activity of IFN-gamma-stimulated monocytes against human squamous carcinoma cell line HSC3 was inhibited partially by anti-TWEAK mAb alone and almost completely by combination with anti-
TRAIL
(TNF-related apoptosis-inducing ligand) mAb. These results revealed a novel pathway of monocyte cytotoxicity against tumor cells that is mediated by TWEAK and potentiated by IFN-gamma.
...
PMID:Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. 1106 85
Invasive fungal infections represent an increasing problem associated with high mortality. The present study was undertaken to identify leukocyte subsets that are activated by hyphal fragments in a whole-human-blood model, as well as to examine the involvement of CD14 and Toll-like receptors (TLRs) in activation of monocytes by hyphae. Incubation of whole human blood with hyphal fragments from Aspergillus fumigatus and Scedosporium prolificans for 6 h caused induction of mRNAs for tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 in T cells, B cells, and monocytes, but not in granulocytes, as analyzed by reverse transcription-PCR with mRNA isolated from very pure populations of these leukocyte subsets. In primary adherent human monocytes, induction of TNF-alpha by hyphal fragments was dependent on plasma. Heat treatment of plasma at 56 degrees C for 30 min strongly reduced the ability of plasma to prime for activation. Pretreatment of human monocytes with different concentrations (1, 3, and 10 microg/ml) of monoclonal antibody (MAb) HTA125 (anti-TLR4) or MAb 18D11 (anti-CD14) for 30 min inhibited the release of TNF-alpha induced by hyphal fragments in a dose-dependent manner. Maximal inhibitions of 35 and 70% were obtained with 10 microg of HTA125 and 18D11 per ml, respectively. In contrast, pretreatment with MAb
TL2
.1 (anti-TLR2) did not affect signaling induced by hyphae. Pretreatment with the lipid A antagonist B975 blocked
lipopolysaccharide
signaling but did not inhibit TNF-alpha production induced by hyphal fragments. Our results suggest that T cells, B cells, and monocytes are involved in the innate immune response to invasive fungal pathogens and that serum components are relevant for activation of monocytes by hyphae. CD14 and TLR4 may be involved in signaling of Aspergillus hyphae in monocytes, but further studies to elucidate this issue are warranted.
...
PMID:Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. 1125
HIV-1 infection in the brain induces neuronal apoptosis leading to HIV-associated dementia. To explore the underlying mechanism, we developed a murine model by using human peripheral blood mononuclear cell (PBMC)-transplanted nonobese diabetic (NOD)-severe combined immunodeficiency (SCID) (hu-PBMC-NOD-SCID) mice. Administration of
lipopolysaccharide
(
LPS
) to HIV-1-infected hu-PBMC-NOD-SCID mice induced infiltration of HIV-1-infected human cells into the perivascular region of the brain and neuronal apoptosis was found in macrophage (M)-tropic but not T cell (T)-tropic HIV-1-infected brains. The apoptotic neurons were frequently colocalized with the HIV-1-infected macrophages that expressed tumor necrosis factor (TNF)-related apoptosis-inducing ligand (
TRAIL
). Administration of a neutralizing antibody against human
TRAIL
but not human TNF-alpha or Fas ligand (FasL) blocked the neuronal apoptosis in the HIV-1-infected brain. These results strongly suggest a critical contribution of
TRAIL
expressed on HIV-1-infected macrophages to neuronal apoptosis.
...
PMID:Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. 1260 Nov 60
In this study, it is reported that neonatal murine microglia and N9 murine microglial cell line express tumor necrosis factor (TNF)-related apoptosis-inducing ligand (
TRAIL
).
TRAIL
protein and mRNA expression in murine microglia greatly upregulate upon stimulation with interferon gamma (IFNgamma) or
lipopolysaccharide
(
LPS
) as revealed by immunoprecipitation-immunoblotting, reverse transcriptase-polymerase chain reaction (RT-PCR) and flow cytometry techniques. IFNgamma and
LPS
act synergistically to induce
TRAIL
expression on both translational and transcriptional levels. The upregulated microglial
TRAIL
in inflammatory conditions may involve in the cytotoxic effect of these cells and play a role in neurodegenerative processes.
...
PMID:Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia. 1266 42
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (
TRAIL
) is a member of the TNF/nerve growth factor superfamily that, apart from inducing cell death in susceptible cells, displays immunoregulatory functions influencing, for instance, T cell proliferation. It can be found in two forms: membrane-bound and soluble protein. The regulation of these is still not fully understood. In this study, we have analyzed the regulation of
TRAIL
surface expression and secretion in human T cells, B cells, and monocytes in response to specific stimuli. T cells, B cells, and monocytes were cultured in the presence of phytohemagglutinin (PHA)+interleukin (IL-2), anti-CD40+IL-4, and
lipopolysaccharide
(
LPS
), respectively. In particular, not only PHA+IL-2 but also
LPS
were able to induce secretion of soluble
TRAIL
, but did not enhance the expression of surface-bound
TRAIL
. Simultaneously, we investigated the effect of the pleiotropic stimulus interferon (IFN)-beta, known to target all leukocyte subsets, on
TRAIL
. Predominantly, monocytes were affected by IFN-beta, causing both release of soluble
TRAIL
and upregulation of the surface-bound form. IFN-beta, however, did not cause any upregulation of
TRAIL
in T cells. Our data serve as a basis to better understand the complex regulation of
TRAIL
in human peripheral immune cells and might help to clarify the role of the
TRAIL
system in immunopathology.
...
PMID:Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. 1460 66
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (
TRAIL
) is a cytotoxic member of the TNF family. Some reports have shown that
TRAIL
is released from cells in a soluble form. In this work, we have investigated the mechanism of release of
TRAIL
from monocytes. First, we show that whole gram-positive, gram-negative and mycoplasmal bacteria as well as
lipopolysaccharide
(
LPS
), interferon-alpha (IFN-alpha), -beta and -gamma all induced upregulation of
TRAIL
on the surface of human monocytes. Next, we show that IFN-alpha, -beta and -gamma all induced a dose-dependent release of
TRAIL
, giving significant amounts of soluble
TRAIL
after 2 days. Of the bacteria, only the Group B streptococcus COH-1 (GBS) induced release of
TRAIL
and concomittantly induced IFN-alpha. Monocytes stimulated with GBS or IFN-alpha also showed extensive cell death. When monocyte apoptosis was prevented by interleukin-1, GM-CSF,
LPS
or the caspase inhibitor zVADfmk, the IFN-alpha-induced release of
TRAIL
was reduced, whereas agents inducing necrosis caused increased release of
TRAIL
.
LPS
also prevented release of
TRAIL
from GBS-stimulated monocytes. The release of
TRAIL
from IFN-alpha-stimulated monocytes was reduced by inhibitors of both cysteine and metalloproteases. We conclude that bacteria and IFN induce upregulation of membrane
TRAIL
and that release of
TRAIL
is associated with cell death.
...
PMID:Monocytes stimulated with group B streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand. 1523 75
CD30 ligand (CD30L) and tumor necrosis factor (TNF)-related apoptosis inducing ligand (
TRAIL
) are members of the TNF-superfamily that have many important biological activities in cell proliferation and apoptotic death. In this study, both genes in the chicken were cloned and their expression was analyzed. Complementary DNA fragments were obtained from a suppressive subtractive hybridization library with or without
lipopolysaccharide
(
LPS
)-stimulation. Chicken CD30L consists of 1,152 base pairs (bp) with an open reading frame (ORF) of 720 bp having 36.4% identity with human CD30L, whereas chicken
TRAIL
is 1,134 bp long with an ORF of 912 bp having 54.4% identity with human
TRAIL
. Chicken CD30L was expressed at high levels in the spleen, bursa of Fabricius and in the chicken monocytic leukemia cell line, IN24. Stimulation with
LPS
in the spleen, bursa of Fabricius and the IN24 cell line did not affect CD30L expression. The gene expression of chicken
TRAIL
was essentially to the same level in all tissues examined. The time course of expression was not significantly altered by
LPS
-stimulation in the spleen, thymus and bursa of Fabricius, but reached a maximal level 8 hr after stimulation in the IN24 cell line. The high level expression of both genes in lymphoid organs and IN24 cell line indicates that chicken CD30L and
TRAIL
may also play an important role in apoptotic signal transduction and the regulation of cell proliferation in the immune system.
...
PMID:Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL). 1524 Sep 38
We used an experimental murine cancer metastasis model in which a colon adenocarcinoma cell line generates lung metastases, whose growth is stimulated in response to injection of bacterial
lipopolysaccharide
(
LPS
), to investigate the role of NF-kappaB in inflammation-induced tumor growth. We found that
LPS
-induced metastatic growth response in this model depends on both TNFalpha production by host hematopoietic cells and NF-kappaB activation in tumor cells. Inhibition of NF-kappaB in both colon and mammary carcinoma cells converts the
LPS
-induced growth response to
LPS
-induced tumor regression. The latter response is TNFalpha-independent, but depends on another member of the TNF superfamily,
TRAIL
, whose receptor is induced in NF-kappaB-deficient cancer cells.
...
PMID:Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. 1538 May 20
1
2
3
Next >>